Nobilis Health Corp.
NRTSF · OTC
12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | |
|---|---|---|---|---|
| Market Cap | $105 | $161 | $189 | $140 |
| - Cash | $23 | $25 | $16 | $8 |
| + Debt | $137 | $84 | $45 | $21 |
| Enterprise Value | $219 | $220 | $218 | $153 |
| Revenue | $300 | $286 | $229 | $84 |
| % Growth | 4.9% | 24.7% | 172.8% | – |
| Gross Profit | $187 | $176 | $151 | $61 |
| % Margin | 62.4% | 61.6% | 65.9% | 72.4% |
| EBITDA | $34 | $19 | $36 | $22 |
| % Margin | 11.4% | 6.7% | 15.9% | 26.2% |
| Net Income | $4 | $6 | $51 | $7 |
| % Margin | 1.3% | 2.3% | 22.2% | 8% |
| EPS Diluted | 0.05 | 0.08 | 0.68 | 0.14 |
| % Growth | -37.5% | -88.2% | 385.7% | – |
| Operating Cash Flow | $26 | $2 | $7 | $4 |
| Capital Expenditures | -$5 | -$6 | -$4 | -$2 |
| Free Cash Flow | $21 | -$4 | $2 | $2 |